PURPOSE: Neurally adjusted ventilatory assist (NAVA) has been shown to improve patient-ventilator interaction and reduce asynchronies in intubated patients, as opposed to pressure support ventilation (PSV). This is a short-term head-to-head physiologic comparison between PSV and NAVA in delivering noninvasive ventilation through a helmet (h-NIV), in patients with postextubation hypoxemic acute respiratory failure. METHODS: Ten patients underwent three 20-min trials of h-NIV in PSV, NAVA, and PSV again. Arterial blood gases (ABGs) were assessed at the end of each trial. Diaphragm electrical activity (EAdi) and airway pressure (P (aw)) were recorded to derive neural and mechanical respiratory rate and timing, inspiratory (delay(TR-insp)) and expiratory trigger delays (delay(TR-exp)), time of synchrony between diaphragm contraction and ventilator assistance (time(synch)), and the asynchrony index (AI). RESULTS: ABGs, peak EAdi, peak P (aw), respiratory rate, either neural or mechanical, neural timing, and delay(TR-exp) were not different between trials. Compared with PSV, with NAVA the mechanical expiratory time was significantly shorter, while the inspiratory time and duty cycle were greater. Time(synch) was 0.79 ± 0.35 s in NAVA versus 0.60 ± 0.30 s and 0.55 ± 0.29 s during the PSV trials (p < 0.01 for both). AI exceeded 10% during both PSV trials, while not in NAVA (p < 0.001). CONCLUSIONS: Compared with PSV, NAVA improves patient-ventilator interaction and synchrony, with no difference in gas exchange, respiratory rate, and neural drive and timing.
PURPOSE: Neurally adjusted ventilatory assist (NAVA) has been shown to improve patient-ventilator interaction and reduce asynchronies in intubated patients, as opposed to pressure support ventilation (PSV). This is a short-term head-to-head physiologic comparison between PSV and NAVA in delivering noninvasive ventilation through a helmet (h-NIV), in patients with postextubation hypoxemic acute respiratory failure. METHODS: Ten patients underwent three 20-min trials of h-NIV in PSV, NAVA, and PSV again. Arterial blood gases (ABGs) were assessed at the end of each trial. Diaphragm electrical activity (EAdi) and airway pressure (P (aw)) were recorded to derive neural and mechanical respiratory rate and timing, inspiratory (delay(TR-insp)) and expiratory trigger delays (delay(TR-exp)), time of synchrony between diaphragm contraction and ventilator assistance (time(synch)), and the asynchrony index (AI). RESULTS: ABGs, peak EAdi, peak P (aw), respiratory rate, either neural or mechanical, neural timing, and delay(TR-exp) were not different between trials. Compared with PSV, with NAVA the mechanical expiratory time was significantly shorter, while the inspiratory time and duty cycle were greater. Time(synch) was 0.79 ± 0.35 s in NAVA versus 0.60 ± 0.30 s and 0.55 ± 0.29 s during the PSV trials (p < 0.01 for both). AI exceeded 10% during both PSV trials, while not in NAVA (p < 0.001). CONCLUSIONS: Compared with PSV, NAVA improves patient-ventilator interaction and synchrony, with no difference in gas exchange, respiratory rate, and neural drive and timing.
Authors: Paolo Navalesi; Roberta Costa; Piero Ceriana; Annalisa Carlucci; George Prinianakis; Massimo Antonelli; Giorgio Conti; Stefano Nava Journal: Intensive Care Med Date: 2006-10-13 Impact factor: 17.440
Authors: Nicolas Terzi; Iris Pelieu; Lydia Guittet; Michel Ramakers; Amélie Seguin; Cédric Daubin; Pierre Charbonneau; Damien du Cheyron; Frédéric Lofaso Journal: Crit Care Med Date: 2010-09 Impact factor: 7.598
Authors: Laurence Vignaux; Frédéric Vargas; Jean Roeseler; Didier Tassaux; Arnaud W Thille; Michel P Kossowsky; Laurent Brochard; Philippe Jolliet Journal: Intensive Care Med Date: 2009-01-29 Impact factor: 17.440
Authors: Lukas Brander; Howard Leong-Poi; Jennifer Beck; Fabrice Brunet; Stuart J Hutchison; Arthur S Slutsky; Christer Sinderby Journal: Chest Date: 2008-11-18 Impact factor: 9.410
Authors: Lise Piquilloud; Didier Tassaux; Emilie Bialais; Bernard Lambermont; Thierry Sottiaux; Jean Roeseler; Pierre-François Laterre; Philippe Jolliet; Jean-Pierre Revelly Journal: Intensive Care Med Date: 2012-08-03 Impact factor: 17.440
Authors: Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2012-02-14 Impact factor: 17.440
Authors: Lucia Mirabella; Giacomo Grasselli; Jack J Haitsma; Haibo Zhang; Arthur S Slutsky; Christer Sinderby; Jennifer Beck Journal: Crit Care Date: 2014-01-23 Impact factor: 9.097
Authors: Jonne Doorduin; Christer A Sinderby; Jennifer Beck; Johannes G van der Hoeven; Leo M A Heunks Journal: Crit Care Date: 2014-10-13 Impact factor: 9.097